Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation
Enrico Maffini(Istituto di Ematologia di Bologna), Benedetto Bruno(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Moreno Festuccia(University of Turin), Mario Boccadoro(University of Turin), Lucia Brunello(University of Turin), Luisa Giaccone(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)
Cited by 106
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
|Leukemia|2008|808
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
|Leukemia|2011|721
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
|New England Journal of Medicine|2023|538